Mirum Pharmaceuticals, Inc. (MIRM) › Capital ExpendituresMirum Pharmaceuticals, Inc. (MIRM) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2019: $281.0K2020: $225.0K2021: $24.0K2022: $278.0K2023: $109.0K2024: $993.0K2025: $954.0K$954.0K2019Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$954.0K-3.9%2024$993.0K+811.0%2023$109.0K-60.8%2022$278.0K+1058.3%2021$24.0K-89.3%2020$225.0K-19.9%2019$281.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share